Kevin Michael Foote

Person

Macclesfield, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds
- Patent number 10,301,267
- Issue date May 28, 2019
- Astrazeneca AB
- David Buttar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating cancer with a pyrazole derivative
- Patent number 9,688,640
- Issue date Jun 27, 2017
- Astrazeneca AB
- David Buttar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 9,421,213
- Issue date Aug 23, 2016
- Astrazeneca AB
- Kevin Michael Foote
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chemical compounds
- Patent number 9,155,742
- Issue date Oct 13, 2015
- Astrazeneca AB
- Kevin Michael Foote
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chemical compounds
- Patent number 8,999,997
- Issue date Apr 7, 2015
- Astrazeneca AB
- Kevin Foote
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethy...
- Patent number 8,604,022
- Issue date Dec 10, 2013
- Astrazeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridine compounds
- Patent number 8,569,298
- Issue date Oct 29, 2013
- Astrazeneca AB
- Bernard Christophe Barlaam
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 8,552,004
- Issue date Oct 8, 2013
- Astrazeneca AB
- Kevin Michael Foote
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Chemical compounds
- Patent number 8,252,802
- Issue date Aug 28, 2012
- Astrazeneca AB
- Kevin Michael Foote
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethy...
- Patent number 8,129,391
- Issue date Mar 6, 2012
- Astrazeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethy...
- Patent number 7,737,149
- Issue date Jun 15, 2010
- Astrazeneca AB
- David Buttar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chemical compounds
- Patent number 7,547,722
- Issue date Jun 16, 2009
- Astrazeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinzoline derivatives for use in the treatment of cancer
- Patent number 7,504,408
- Issue date Mar 17, 2009
- Astrazeneca AB
- Laurent Francois Andre Hennequin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Carbazole derivatives and their use as NPY5 receptor antagonists
- Patent number 7,408,064
- Issue date Aug 5, 2008
- Astrazeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinolines as antitumor agents
- Patent number 7,402,583
- Issue date Jul 22, 2008
- AstrZenca AB
- Francis Thomas Boyle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amino substituted dibenzothiophene derivatives for the treatment of...
- Patent number 7,332,492
- Issue date Feb 19, 2008
- Astrazeneca AB
- Michael Howard Block
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6H-THIENO [2,3-b]pyrrole derivatives as antagonists of gonadotropin...
- Patent number 7,268,158
- Issue date Sep 11, 2007
- Astrazeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 3-cyanoquinolines as MEK inhibitors
- Patent number 7,173,135
- Issue date Feb 6, 2007
- Astrazeneca AB
- Laurent Francois Andre Hennequin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
6H-thieno[2, 3-b]pyrrole derivatives as antagonists of gonadotropin...
- Patent number 7,132,442
- Issue date Nov 7, 2006
- Astrazeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinolines as antitumor agents
- Patent number 7,067,532
- Issue date Jun 27, 2006
- AstraZeneca
- Francis Thomas Boyle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Amino substituted dibenzothiophene derivatives for the treatment of...
- Patent number 6,967,216
- Issue date Nov 22, 2005
- Astrazeneca AB
- Michael Howard Block
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NOVEL COMPOUNDS
- Publication number 20170260143
- Publication date Sep 14, 2017
- AstraZeneca AB
- David BUTTAR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical Compounds
- Publication number 20160074412
- Publication date Mar 17, 2016
- AstraZeneca AB
- Kevin Michael Foote
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20150299134
- Publication date Oct 22, 2015
- AstraZeneca AB
- David BUTTAR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Chemical Compounds
- Publication number 20150164908
- Publication date Jun 18, 2015
- AstraZeneca AB
- Kevin Michael Foote
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20140066455
- Publication date Mar 6, 2014
- AstraZeneca AB
- David BUTTAR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMICAL COMPOUNDS
- Publication number 20140018364
- Publication date Jan 16, 2014
- AstraZeneca AB
- Kevin FOOTE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CHEMICAL COMPOUNDS
- Publication number 20130005725
- Publication date Jan 3, 2013
- AstraZeneca AB
- Kevin Michael Foote
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-[5-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-3-YL]-4-(3,4-DIMETHY...
- Publication number 20120129844
- Publication date May 24, 2012
- AstraZeneca AB
- David Buttar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMICAL COMPOUNDS
- Publication number 20110306613
- Publication date Dec 15, 2011
- AstraZeneca AB
- Kevin Michael Foote
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRIDINE COMPOUNDS
- Publication number 20110166139
- Publication date Jul 7, 2011
- AstraZeneca AB
- Bernard Christophe Barlaam
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMICAL COMPOUNDS 610
- Publication number 20110053923
- Publication date Mar 3, 2011
- AstraZeneca
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethy...
- Publication number 20100273811
- Publication date Oct 28, 2010
- AstraZeneca AB
- David Buttar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLYLAMINO SUBSTITUTED QUINAZOLES FOR THE TREATMENT OF CANCER
- Publication number 20100022476
- Publication date Jan 28, 2010
- AstraZeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Indole Derivatives
- Publication number 20090306126
- Publication date Dec 10, 2009
- AstraZeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRAZOLE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS
- Publication number 20090118336
- Publication date May 7, 2009
- Laurent David
- C07 - ORGANIC CHEMISTRY
Information Patent Application
THIAZOLE DERIVATIVES AND THEIR USE AS ANTI-TUMOUR AGENTS
- Publication number 20090076009
- Publication date Mar 19, 2009
- Jean-Claude (Retired) Arnould
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa
- Publication number 20080214495
- Publication date Sep 4, 2008
- AstraZeneca AB
- Christer Alstermark
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinazolines and Their Use as Aurora Kinase Inhibitors
- Publication number 20080194556
- Publication date Aug 14, 2008
- AstraZeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL COMPOUNDS
- Publication number 20080153812
- Publication date Jun 26, 2008
- AstraZeneca AB
- David Buttar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
6H-THIENO[2,3-b]PYRROLE DERIVATIVES AS ANTAGONISTS OF GONADOTROPIN...
- Publication number 20080045517
- Publication date Feb 21, 2008
- AstraZeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Novel Compounds
- Publication number 20080004302
- Publication date Jan 3, 2008
- AstraZeneca AB
- Maria-Elena Theoclitou
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted 3-cyanoquinolines as MEK inhibitors
- Publication number 20070213367
- Publication date Sep 13, 2007
- AstraZeneca AB
- Laurent Francois Andre Hennequin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted quinolines as antitumor agents
- Publication number 20070021407
- Publication date Jan 25, 2007
- ASTRAZENECA
- Francis Thomas Boyle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
6H-THIENO[2,3-b]PYRROLE DERIVATIVES AS ANTAGONISTS OF GONADOTROPIN...
- Publication number 20060235067
- Publication date Oct 19, 2006
- AstraZeneca AB
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted 3-cyanoquinolines as mek inhibitors
- Publication number 20060089382
- Publication date Apr 27, 2006
- Laurent Francois Andre Hennequin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
6H-thieno'2, 3-b!pyrrole derivatives as antagonists of gonadotropin...
- Publication number 20060004082
- Publication date Jan 5, 2006
- AstraZeneca
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Quinzoline derivatives for use in the treatment of cancer
- Publication number 20050250797
- Publication date Nov 10, 2005
- ASTRAZENECA AB
- Laurent Francois Andre Hennequin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Amino substituted dibenzothiophene derivatives for the treatment of...
- Publication number 20050209233
- Publication date Sep 22, 2005
- AstraZeneca AB
- Michael Howard Block
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Carbazole derivatives and their use as npy5 receptor antagonists
- Publication number 20050065157
- Publication date Mar 24, 2005
- Kevin Michael Foote
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Carbazole derivatives and their use as neuropeptide y5 receptor lig...
- Publication number 20040067999
- Publication date Apr 8, 2004
- Michael Howard Block
- C07 - ORGANIC CHEMISTRY

Kevin Michael Foote

Person

Patents Grantslast 30 patents

Compounds

Methods of treating cancer with a pyrazole derivative

Chemical compounds

Chemical compounds

Chemical compounds

N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1h-pyrazol-3-yl]-4-(3,4-dimethy...

Pyridine compounds

Chemical compounds

Chemical compounds

N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethy...

N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethy...

Chemical compounds

Quinzoline derivatives for use in the treatment of cancer

Carbazole derivatives and their use as NPY5 receptor antagonists

Substituted quinolines as antitumor agents

Amino substituted dibenzothiophene derivatives for the treatment of...

6H-THIENO [2,3-b]pyrrole derivatives as antagonists of gonadotropin...

Substituted 3-cyanoquinolines as MEK inhibitors

6H-thieno[2, 3-b]pyrrole derivatives as antagonists of gonadotropin...

Substituted quinolines as antitumor agents

Amino substituted dibenzothiophene derivatives for the treatment of...

Patents Applicationslast 30 patents

NOVEL COMPOUNDS

Chemical Compounds

NOVEL COMPOUNDS

Chemical Compounds

NOVEL COMPOUNDS

CHEMICAL COMPOUNDS

CHEMICAL COMPOUNDS

N-[5-[2-(3,5-DIMETHOXYPHENYL)ETHYL]-1H-PYRAZOL-3-YL]-4-(3,4-DIMETHY...

CHEMICAL COMPOUNDS

PYRIDINE COMPOUNDS

CHEMICAL COMPOUNDS 610

N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-(3,4-dimethy...

PYRAZOLYLAMINO SUBSTITUTED QUINAZOLES FOR THE TREATMENT OF CANCER

Indole Derivatives

PYRAZOLE DERIVATIVES AND THEIR USE AS PI3K INHIBITORS

THIAZOLE DERIVATIVES AND THEIR USE AS ANTI-TUMOUR AGENTS

Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa

Quinazolines and Their Use as Aurora Kinase Inhibitors

NOVEL COMPOUNDS

6H-THIENO[2,3-b]PYRROLE DERIVATIVES AS ANTAGONISTS OF GONADOTROPIN...

Novel Compounds

Substituted 3-cyanoquinolines as MEK inhibitors

Substituted quinolines as antitumor agents

6H-THIENO[2,3-b]PYRROLE DERIVATIVES AS ANTAGONISTS OF GONADOTROPIN...

Substituted 3-cyanoquinolines as mek inhibitors

6H-thieno'2, 3-b!pyrrole derivatives as antagonists of gonadotropin...

Quinzoline derivatives for use in the treatment of cancer

Amino substituted dibenzothiophene derivatives for the treatment of...

Carbazole derivatives and their use as npy5 receptor antagonists

Carbazole derivatives and their use as neuropeptide y5 receptor lig...